Lupin Pharma Canada, Endoceutics to partner for commercialisation of Intrarosa EP News Bureau Mar 9, 2021 It is indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of…
